Literature DB >> 19437086

Scleroderma (systemic sclerosis) among Nigerians.

O O Adelowo1, S Oguntona.   

Abstract

Scleroderma and other connective tissue diseases have rarely been reported among Africans. The objective of this paper is to have a retrospective study of the clinical and investigative characteristics of scleroderma patients seen in a rheumatology clinic. This was done in a private practice rheumatology clinic in Lagos, Nigeria. Patients were identified using the American College of Rheumatology criteria for diagnosis of scleroderma. A total of 14 cases of scleroderma are reported. Most of the patients were females and diffuse scleroderma was more frequently seen. Arthritis and reflux esophagitis were the most common nondermatological presentation while Raynaud's phenomenon and dysphagia were the least seen. Restrictive pattern of lung function tests were seen in most of those tested and pulmonary fibrosis was seen in some cases. Antinuclear antibodies were the commonest serological findings with the speckled staining pattern in most cases. Treatments were with standard medications. Scleroderma among Nigerians is rare as elsewhere and there are certain common characteristics as seen elsewhere as well as certain differences.

Entities:  

Mesh:

Year:  2009        PMID: 19437086     DOI: 10.1007/s10067-009-1191-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  18 in total

1.  Symptoms of Raynaud's phenomenon in an inner-city African-American community: prevalence and self-reported cardiovascular comorbidity.

Authors:  A C Gelber; F M Wigley; R Y Stallings; L R Bone; A V Barker; I Baylor; C W Harris; M N Hill; S L Zeger; D M Levine
Journal:  J Clin Epidemiol       Date:  1999-05       Impact factor: 6.437

2.  Prevalence of Raynaud phenomenon in the general population. A preliminary study by questionnaire.

Authors:  H R Maricq; M C Weinrich; J E Keil; E C LeRoy
Journal:  J Chronic Dis       Date:  1986

3.  Racial differences in the distribution of systemic sclerosis-related serum antinuclear antibodies.

Authors:  M Kuwana; Y Okano; J Kaburaki; T Tojo; T A Medsger
Journal:  Arthritis Rheum       Date:  1994-06

4.  Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982.

Authors:  V D Steen; C V Oddis; C G Conte; J Janoski; G Z Casterline; T A Medsger
Journal:  Arthritis Rheum       Date:  1997-03

5.  Clinical and laboratory manifestations of systemic sclerosis (scleroderma) in Black South Africans.

Authors:  R E Tager; M Tikly
Journal:  Rheumatology (Oxford)       Date:  1999-05       Impact factor: 7.580

6.  Racial differences in scleroderma among women in Michigan.

Authors:  T J Laing; B W Gillespie; M B Toth; M D Mayes; R H Gallavan; C J Burns; J R Johanns; B C Cooper; B J Keroack; M C Wasko; J V Lacey; D Schottenfeld
Journal:  Arthritis Rheum       Date:  1997-04

7.  Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee.

Authors: 
Journal:  Arthritis Rheum       Date:  1980-05

8.  Epidemiology of systemic lupus erythematosus and other connective tissue diseases in Rochester, Minnesota, 1950 through 1979.

Authors:  C J Michet; C H McKenna; L R Elveback; R A Kaslow; L T Kurland
Journal:  Mayo Clin Proc       Date:  1985-02       Impact factor: 7.616

9.  Epidemiology of systemic sclerosis (scleroderma).

Authors:  T A Medsger; A T Masi
Journal:  Ann Intern Med       Date:  1971-05       Impact factor: 25.391

10.  Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population.

Authors:  Maureen D Mayes; James V Lacey; Jennifer Beebe-Dimmer; Brenda W Gillespie; Brenda Cooper; Timothy J Laing; David Schottenfeld
Journal:  Arthritis Rheum       Date:  2003-08
View more
  7 in total

1.  Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.

Authors:  Cristiane Mendes; Vilma S T Viana; Sandra G Pasoto; Elaine P Leon; Eloisa Bonfa; Percival D Sampaio-Barros
Journal:  Clin Rheumatol       Date:  2019-05-07       Impact factor: 2.980

2.  Vascular involvement in systemic sclerosis (scleroderma).

Authors:  Debendra Pattanaik; Monica Brown; Arnold E Postlethwaite
Journal:  J Inflamm Res       Date:  2011-07-26

3.  Antiphospholipid antibodies and systemic scleroderma.

Authors:  Awa Oumar Touré; Fatimata Ly; Abibatou Sall; Alassane Diatta; Macoura Gadji; Moussa Seck; Blaise Faye; Tandakha Dieye; Saliou Diop
Journal:  Turk J Haematol       Date:  2013-03-05       Impact factor: 1.831

Review 4.  Dermatologic conditions in patients of color who are pregnant.

Authors:  C Jeon; O Agbai; D Butler; J Murase
Journal:  Int J Womens Dermatol       Date:  2017-03-24

Review 5.  Rheumatic diseases in Africa.

Authors:  Olufemi Adelowo; Girish M Mody; Mohammed Tikly; Omondi Oyoo; Samy Slimani
Journal:  Nat Rev Rheumatol       Date:  2021-04-13       Impact factor: 20.543

6.  Salt-and-pepper Appearance: A Cutaneous Clue for the Diagnosis of Systemic Sclerosis.

Authors:  Ashish Singh; S Ambujam; Asha Varghese; S P Vishranth; Neenu Sadanandan
Journal:  Indian J Dermatol       Date:  2012-09       Impact factor: 1.494

7.  [Connective tissue diseases in the hospital setting in Lomé: a retrospective study of 231 cases].

Authors:  Julienne Noude Teclessou; Bayaki Saka; Séfako Abla Akakpo; Houassou Matakloe; Abas Mouhari-Toure; Kousaké Kombate; Inoussa Oniankitan; Palokinam Pitche
Journal:  Pan Afr Med J       Date:  2018-06-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.